Antimicrobial Resistance in the Asia Pacific region: a meeting report.
Antimicrobial Resistance
Asia Pacific
Drug Resistance
Global Health
Global Mobility
One Health
Singapore
Travel
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
2019
2019
Historique:
received:
20
05
2019
accepted:
14
11
2019
entrez:
1
1
2020
pubmed:
1
1
2020
medline:
18
7
2020
Statut:
epublish
Résumé
The Asia Pacific region, home to two-thirds of the world's population and ten of the least developed countries, is considered a regional hot-spot for the emergence and spread of antimicrobial resistance (AMR). Despite this, there is a dearth of high-quality regional data on the extent of AMR. Recognising the urgency to close this gap, Singapore organised a meeting to discuss the problems in the region and frame a call for action. Representatives from across the region and beyond attended the meeting on the "Antimicrobial Resistance in the Asia Pacific & its impact on Singapore" held in November 2018. This meeting report is a summary of the discussions on the challenges and progress in surveillance, drivers and levers of AMR emergence, and the promising innovations and technologies that could be used to combat the increasing threat of AMR in the region. Enhanced surveillance and research to provide improved evidence-based strategies and policies are needed. The major themes that emerged for an action plan are working towards a tailored solution for the region by harnessing the One Health approach, enhancing inter-country collaborations, and collaboratively leverage upon new emerging technologies. A regionally coordinated effort that is target-driven, sustainable and builds on a framework facilitating communication and governance will strengthen the fight against AMR in the Asia Pacific region.
Identifiants
pubmed: 31890158
doi: 10.1186/s13756-019-0654-8
pii: 654
pmc: PMC6921568
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Congress
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
202Informations de copyright
© The Author(s). 2019.
Déclaration de conflit d'intérêts
Competing interestsNo conflict of interest to declare.
Références
J Travel Med. 2018 Aug 1;25(1):
pubmed: 30169854
Lab Chip. 2014 Sep 21;14(18):3519-24
pubmed: 25008551
Lancet Glob Health. 2017 Mar;5(3):e246-e247
pubmed: 28108138
J Travel Med. 2017 Apr 1;24(suppl_1):S35-S38
pubmed: 28520993
Clin Infect Dis. 2018 Nov 8;:null
pubmed: 30407501
J Travel Med. 2018 Jan 1;25(1):
pubmed: 30312427
BMJ. 2013 Mar 11;346:f1493
pubmed: 23479660
Elife. 2016 Sep 06;5:
pubmed: 27599374
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
Antimicrob Resist Infect Control. 2016 Dec 20;5:58
pubmed: 28031814
J Travel Med. 2018 Aug 1;25(1):
pubmed: 30124885
J Travel Med. 2018 Jan 1;25(1):
pubmed: 29232454
Lancet Infect Dis. 2011 Sep;11(9):692-701
pubmed: 21659004
J Antibiot (Tokyo). 2017 Dec;70(12):1087-1096
pubmed: 29089600
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Infect Chemother. 2013 Mar;45(1):22-31
pubmed: 24265947
ISME J. 2016 Feb;10(2):427-36
pubmed: 26394010
J Travel Med. 2017 Apr 1;24(suppl_1):S57-S62
pubmed: 28881862
J Glob Antimicrob Resist. 2014 Sep;2(3):141-147
pubmed: 27873720
J Travel Med. 2019 Dec 23;26(8):null
pubmed: 31115466
BMJ. 2017 Sep 5;358:j2291
pubmed: 28874360
Microb Ecol. 2017 Nov;74(4):1001-1008
pubmed: 28492988
Nanobiomedicine (Rij). 2015;2:
pubmed: 26594252
J Travel Med. 2017 Mar 1;24(2):
pubmed: 28395100
J Travel Med. 2017 Apr 1;24(suppl_1):S6-S12
pubmed: 28520997
Anal Chem. 2018 Aug 7;90(15):9472-9479
pubmed: 29924932
Microbiome. 2017 Nov 13;5(1):148
pubmed: 29132405
J Travel Med. 2016 Aug 08;23(6):
pubmed: 27503854
Int J Clin Pharm. 2015 Dec;37(6):1213-21
pubmed: 26391787
J Travel Med. 2014 Jul-Aug;21(4):272-81
pubmed: 24894491
Antimicrob Resist Infect Control. 2017 Mar 24;6:30
pubmed: 28352463
J Travel Med. 2019 Jan 1;26(1):null
pubmed: 30462253
J Travel Med. 2016 Feb 08;23(2):tav024
pubmed: 26858272
J Health Econ. 2005 Nov;24(6):1055-75
pubmed: 16139909
Health Commun. 2017 Oct;32(10):1201-1209
pubmed: 27613075
Lancet. 2016 Jan 9;387(10014):188-98
pubmed: 26603919
J Antimicrob Chemother. 2017 Nov 1;72(11):2963-2972
pubmed: 28961709
Trends Biotechnol. 2019 Mar;37(3):253-267
pubmed: 30241924
Trop Dis Travel Med Vaccines. 2017 May 4;3:9
pubmed: 28883979
J Travel Med. 2018 Jan 1;25(1):
pubmed: 29462444
J Travel Med. 2018 May 1;25(suppl_1):S27-S37
pubmed: 29718437
BMJ. 2017 Sep 5;358:j3393
pubmed: 28874338
J Travel Med. 2018 Jan 1;25(1):
pubmed: 30060197
J Glob Antimicrob Resist. 2018 Jun;13:135-138
pubmed: 29277727
Front Immunol. 2019 Jan 07;9:2868
pubmed: 30666248
Clin Microbiol Infect. 2014 Oct;20(10):973-80
pubmed: 25273968
Am J Trop Med Hyg. 2017 Oct;97(4):1257-1261
pubmed: 28722626
J Antimicrob Chemother. 2018 Apr 1;73(4):1110-1111
pubmed: 29365120
Lancet Infect Dis. 2018 Jun;18(6):603-604
pubmed: 29856355
Biosens Bioelectron. 2018 Apr 15;102:456-463
pubmed: 29182928
J Travel Med. 2017 Apr 1;24(suppl_1):S44-S51
pubmed: 28521000
J Travel Med. 2017 Jul 1;24(4):
pubmed: 28637267
Lab Chip. 2014 Nov 7;14(21):4237-43
pubmed: 25205636
Lancet Infect Dis. 2018 Jun;18(6):e204-e213
pubmed: 29146178
J Travel Med. 2017 Apr 1;24(suppl_1):S52-S56
pubmed: 28521002
J Antimicrob Chemother. 2018 Jul 1;73(7):1737-1749
pubmed: 29514279
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
J Travel Med. 2016 May 04;23(4):
pubmed: 27147730
Science. 2019 Jan 11;363(6423):181-187
pubmed: 30630933
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54
pubmed: 25792457
J Med Microbiol. 2013 Aug;62(Pt 8):1204-10
pubmed: 23657529
J Travel Med. 2015 Sep-Oct;22(5):289-91
pubmed: 26333539
Nat Rev Microbiol. 2016 Apr;14(4):235-50
pubmed: 26923111
Zoonoses Public Health. 2015 Apr;62 Suppl 1:79-87
pubmed: 25421382
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12902-12910
pubmed: 30559176
Cell Host Microbe. 2018 Feb 14;23(2):229-240.e5
pubmed: 29447696
Immunol Rev. 2017 Sep;279(1):90-105
pubmed: 28856737
Cureus. 2018 Apr 5;10(4):e2428
pubmed: 29876150
Antimicrob Resist Infect Control. 2018 Apr 25;7:58
pubmed: 29713465
Emerg Infect Dis. 2014 Jul;20(7):1170-5
pubmed: 24959688
EMBO Mol Med. 2015 Feb 20;7(3):227-39
pubmed: 25712531
Lancet Infect Dis. 2011 Feb;11(2):131-41
pubmed: 21272793
Am J Respir Crit Care Med. 2014 Aug 15;190(4):445-55
pubmed: 25054455
BMJ. 2017 Sep 5;358:j3808
pubmed: 28874346
N Engl J Med. 2006 Apr 6;354(14):1455-63
pubmed: 16598044
Lancet Infect Dis. 2013 Mar;13(3):269-75
pubmed: 23332713
Mol Syst Biol. 2017 Mar 27;13(3):922
pubmed: 28348067
Lancet Glob Health. 2018 Sep;6(9):e969-e979
pubmed: 30103998
J Travel Med. 2019 Jan 1;26(1):null
pubmed: 30476231
PLoS Negl Trop Dis. 2016 Apr 07;10(4):e0004607
pubmed: 27055163
J Travel Med. 2017 Apr 1;24(suppl_1):S57-S74
pubmed: 28521004
Microbiol Spectr. 2017 Sep;5(5):
pubmed: 28936948
Med Care. 2010 Sep;48(9):767-75
pubmed: 20706168
BMC Med. 2019 Mar 29;17(1):70
pubmed: 30922309
Clin Infect Dis. 2017 May 15;64(suppl_2):S68-S75
pubmed: 28475792
Expert Rev Anti Infect Ther. 2015 Apr;13(4):511-20
pubmed: 25704246
BMC Infect Dis. 2016 May 17;16:208
pubmed: 27188538
Front Microbiol. 2019 Jan 28;10:41
pubmed: 30745898
Crit Care. 2014 Jun 27;18(3):228
pubmed: 25043962